COVID pill is first to cut short positive-test time after infection
The antiviral ensitrelvir, which is not approved in the United States, shortens symptoms in people with mild COVID and might reduce risk of long COVID 鈥?but more data are needed.
The antiviral ensitrelvir, which is not approved in the United States, shortens symptoms in people with mild COVID and might reduce risk of long COVID 鈥?but more data are needed.